A Step Towards Autonomous, Biomimetic, Non-GPS Based Navigation Methodology

Global Positioning System (GPS) based navigations have their own inherent weakness; they can be overridden so easily and are not useful inside structures. One method of overcoming the above problem is the use of feature based navigation system. Nature has so much perfected this that copying nature is one of the best approaches available to scientist. In this study, desert ant (Cataglyphis fortis) was imitated. A simple infra-red based active beacons and robot mounted rotating receiver based on TSOP31138 infra-red sensor was implemented using New Three Objects Triangulation Algorithm (ToTAL) in its firmware for the robot pose. The designed robot with the triangulation algorithm was able to compute its pose such that on a grid of 6 m x 6 m, it can home to its base with a maximum error of 14.8 mm

Effect of Avogadro Oil as Corrosion Inhibitor of Thermally Pre-aged Al-Si-Mg Alloy in Sodium Chloride Solution

The corrosion inhibition of thermally pre-aged Aluminium-Silicon-Magnesium (Al-Si-Mg) alloy in 3.5 % NaCl solution with natural Avogadro oil of varying concentrations has been studied using linear polarization techniques. From the results obtained, the corrosion rate decreased with an increase in Avogadro oil concentration. An inhibitor efficiency of 46.7, 58 and 71 % were obtained at 1.5, 3.0, 4.5 g/v Avogadro oil addition in a 3.5 % NaCl solution respectively for the conventional alloy. Results from the linear polarization technique indicate a higher potential value with an increase in the polarization resistance (Rp) and lower current density in the inhibited samples than the uninhibited Al-Si-Mg alloy as obtained from the Tafel plot extrapolation. There exist some levels of correlation in the inhibitor efficiency between the conventional and the thermally pre-aged Al-Si-Mg alloy/Avogadro oil in 3.5 % NaCl solution

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

Background: Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children worldwide. Immunoglobulin or glucocorticoids, or both, are currently recommended treatments. Methods: The Best Available Treatment Study evaluated immunomodulatory treatments for MIS-C in an international observational cohort. Analysis of the first 614 patients was previously reported. In this propensity-weighted cohort study, clinical and outcome data from children with suspected or proven MIS-C were collected onto a web-based Research Electronic Data Capture database. After excluding neonates and incomplete or duplicate records, inverse probability weighting was used to compare primary treatments with intravenous immunoglobulin, intravenous immunoglobulin plus glucocorticoids, or glucocorticoids alone, using intravenous immunoglobulin as the reference treatment. Primary outcomes were a composite of inotropic or ventilator support from the second day after treatment initiation, or death, and time to improvement on an ordinal clinical severity scale. Secondary outcomes included treatment escalation, clinical deterioration, fever, and coronary artery aneurysm occurrence and resolution. This study is registered with the ISRCTN registry, ISRCTN69546370. Findings: We enrolled 2101 children (aged 0 months to 19 years) with clinically diagnosed MIS-C from 39 countries between June 14, 2020, and April 25, 2022, and, following exclusions, 2009 patients were included for analysis (median age 8·0 years [IQR 4·2–11·4], 1191 [59·3%] male and 818 [40·7%] female, and 825 [41·1%] White). 680 (33·8%) patients received primary treatment with intravenous immunoglobulin, 698 (34·7%) with intravenous immunoglobulin plus glucocorticoids, 487 (24·2%) with glucocorticoids alone; 59 (2·9%) patients received other combinations, including biologicals, and 85 (4·2%) patients received no immunomodulators. There were no significant differences between treatments for primary outcomes for the 1586 patients with complete baseline and outcome data that were considered for primary analysis. Adjusted odds ratios for ventilation, inotropic support, or death were 1·09 (95% CI 0·75–1·58; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids and 0·93 (0·58–1·47; corrected p value=1·00) for glucocorticoids alone, versus intravenous immunoglobulin alone. Adjusted average hazard ratios for time to improvement were 1·04 (95% CI 0·91–1·20; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids, and 0·84 (0·70–1·00; corrected p value=0·22) for glucocorticoids alone, versus intravenous immunoglobulin alone. Treatment escalation was less frequent for intravenous immunoglobulin plus glucocorticoids (OR 0·15 [95% CI 0·11–0·20]; p<0·0001) and glucocorticoids alone (0·68 [0·50–0·93]; p=0·014) versus intravenous immunoglobulin alone. Persistent fever (from day 2 onward) was less common with intravenous immunoglobulin plus glucocorticoids compared with either intravenous immunoglobulin alone (OR 0·50 [95% CI 0·38–0·67]; p<0·0001) or glucocorticoids alone (0·63 [0·45–0·88]; p=0·0058). Coronary artery aneurysm occurrence and resolution did not differ significantly between treatment groups. Interpretation: Recovery rates, including occurrence and resolution of coronary artery aneurysms, were similar for primary treatment with intravenous immunoglobulin when compared to glucocorticoids or intravenous immunoglobulin plus glucocorticoids. Initial treatment with glucocorticoids appears to be a safe alternative to immunoglobulin or combined therapy, and might be advantageous in view of the cost and limited availability of intravenous immunoglobulin in many countries. Funding: Imperial College London, the European Union's Horizon 2020, Wellcome Trust, the Medical Research Foundation, UK National Institute for Health and Care Research, and National Institutes of Health

Virus genomes reveal factors that spread and sustained the Ebola epidemic.

The 2013-2016 West African epidemic caused by the Ebola virus was of unprecedented magnitude, duration and impact. Here we reconstruct the dispersal, proliferation and decline of Ebola virus throughout the region by analysing 1,610 Ebola virus genomes, which represent over 5% of the known cases. We test the association of geography, climate and demography with viral movement among administrative regions, inferring a classic 'gravity' model, with intense dispersal between larger and closer populations. Despite attenuation of international dispersal after border closures, cross-border transmission had already sown the seeds for an international epidemic, rendering these measures ineffective at curbing the epidemic. We address why the epidemic did not spread into neighbouring countries, showing that these countries were susceptible to substantial outbreaks but at lower risk of introductions. Finally, we reveal that this large epidemic was a heterogeneous and spatially dissociated collection of transmission clusters of varying size, duration and connectivity. These insights will help to inform interventions in future epidemics

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

Background Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children worldwide. Immunoglobulin or glucocorticoids, or both, are currently recommended treatments. Methods The Best Available Treatment Study evaluated immunomodulatory treatments for MIS-C in an international observational cohort. Analysis of the first 614 patients was previously reported. In this propensity-weighted cohort study, clinical and outcome data from children with suspected or proven MIS-C were collected onto a web-based Research Electronic Data Capture database. After excluding neonates and incomplete or duplicate records, inverse probability weighting was used to compare primary treatments with intravenous immunoglobulin, intravenous immunoglobulin plus glucocorticoids, or glucocorticoids alone, using intravenous immunoglobulin as the reference treatment. Primary outcomes were a composite of inotropic or ventilator support from the second day after treatment initiation, or death, and time to improvement on an ordinal clinical severity scale. Secondary outcomes included treatment escalation, clinical deterioration, fever, and coronary artery aneurysm occurrence and resolution. This study is registered with the ISRCTN registry, ISRCTN69546370. Findings We enrolled 2101 children (aged 0 months to 19 years) with clinically diagnosed MIS-C from 39 countries between June 14, 2020, and April 25, 2022, and, following exclusions, 2009 patients were included for analysis (median age 8·0 years [IQR 4·2–11·4], 1191 [59·3%] male and 818 [40·7%] female, and 825 [41·1%] White). 680 (33·8%) patients received primary treatment with intravenous immunoglobulin, 698 (34·7%) with intravenous immunoglobulin plus glucocorticoids, 487 (24·2%) with glucocorticoids alone; 59 (2·9%) patients received other combinations, including biologicals, and 85 (4·2%) patients received no immunomodulators. There were no significant differences between treatments for primary outcomes for the 1586 patients with complete baseline and outcome data that were considered for primary analysis. Adjusted odds ratios for ventilation, inotropic support, or death were 1·09 (95% CI 0·75–1·58; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids and 0·93 (0·58–1·47; corrected p value=1·00) for glucocorticoids alone, versus intravenous immunoglobulin alone. Adjusted average hazard ratios for time to improvement were 1·04 (95% CI 0·91–1·20; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids, and 0·84 (0·70–1·00; corrected p value=0·22) for glucocorticoids alone, versus intravenous immunoglobulin alone. Treatment escalation was less frequent for intravenous immunoglobulin plus glucocorticoids (OR 0·15 [95% CI 0·11–0·20]; p<0·0001) and glucocorticoids alone (0·68 [0·50–0·93]; p=0·014) versus intravenous immunoglobulin alone. Persistent fever (from day 2 onward) was less common with intravenous immunoglobulin plus glucocorticoids compared with either intravenous immunoglobulin alone (OR 0·50 [95% CI 0·38–0·67]; p<0·0001) or glucocorticoids alone (0·63 [0·45–0·88]; p=0·0058). Coronary artery aneurysm occurrence and resolution did not differ significantly between treatment groups. Interpretation Recovery rates, including occurrence and resolution of coronary artery aneurysms, were similar for primary treatment with intravenous immunoglobulin when compared to glucocorticoids or intravenous immunoglobulin plus glucocorticoids. Initial treatment with glucocorticoids appears to be a safe alternative to immunoglobulin or combined therapy, and might be advantageous in view of the cost and limited availability of intravenous immunoglobulin in many countries. Funding Imperial College London, the European Union's Horizon 2020, Wellcome Trust, the Medical Research Foundation, UK National Institute for Health and Care Research, and National Institutes of Health

Species\' identification of Anopheles and Culex mosquitoes and its epidemiological implications in Yola, Nigeria

Indoor and outdoor bites' collections of gravid Anopheles and Culex mosquitoes were made with plastic aspirator from residential areas within Jimeta-Yola metropolis for three years (between March and May; August and October 2003 to 2005). They were identified using standard morphological keys and polymerase chain reaction (PCR). The identification results of the dry season collections of Anopheles and Culex mosquitoes using morphological keys were Anopheles gambiae complex (64.0 %), Anopheles funestus complex (17.0 %), Anopheles pharoensis (9.0 %), Anopheles rhodesiensis (5.0%); Culex quinquefasciatus (40.5 %), Culex pipiens fatigans (32.4 %) and Culex tigripes (10.1 %). The results of the wet season collections were Anopheles gambiae complex (56.0 %), Anopheles funestus complex (19.6.0 %) Anopheles pharoensis (11.4 %), Anopheles rhodesiensis (7.0 %); others (4.0 %). There were no significant changes in the relative abundance of different species of Culex mosquitoes due to changes in season, except Culex pipiens fatigans (36.4 %) and Culex tigripes (12.4 %). Results of the PCR identifications confirmed that Anopheles gambiae complex consisted of Anopheles arabiensis (66.7%) and Anopheles gambiae s.s.(6.7%). The study shows that Anopheles and Culex mosquito species abound in the study area with potential health consequences in the transmission of malaria and filariasis all year round. Keywords: gravid, Anopheles, Culex, identification, PCR. Nigerian Journal of Parasitology Vol. 28 (2) 2007: pp. 114-11

Evaluating the Corporate Social Responsibility Disclosure of Nigeria's Most Profitable Companies

This study evaluated Corporate Social Responsibility (CSR) disclosure in the most profitable companies in Nigeria, a review was carried out on the annual reports and websites of the five most profitable companies in Nigeria according to the market cap list 2018. This research focused on the quantity and quality of CSR disclosures, provided by these companies. The method of analysis used was content analysis. The result of this study revealed that from the three dimensions constituting Community disclosure, Environmental disclosure and Human Resource disclosure, Community disclosure was the most disclosed dimension from the top profitable companies in Nigeria. Findings revealed that these companies disclosed a lot about the different CSR activities they had undertaken within the span of one year, but the quality of these disclosures were relatively low. CSR disclosure should be encouraged by the Nigerian government by publicly recognizing companies who disclose CSR activity, this will motivate other companies to practice and disclose CSR

Corrosion Inhibition Study of Al-Cu-Ni Alloy in Simulated Sea-Water Environment

A study on the inhibition of Al-Cu-Ni alloy in simulated sea-water environment was investigated using Sodium Chromate as inhibitor. The inhibitor concentration was varied as control, 0.25, 0.5, 1.0, 1.5 and 2.0 Molar. Al-Cu-Ni alloy was sand cast into cylindrical bars of 20 mm x 300 mm dimension. The corrosion of the sand-cast and treated alloys in 3.5wt% sodium chloride solution at temperatures 30oC, 50oC and 70oC over 1-5 hrs was evaluated using the weight loss method. It was observed that the corrosion rate of the treated alloys decreases with increase in inhibitor concentration. The decrease in corrosion rate on addition of the inhibitor can be attributed to the adsorption of the inhibitor onto the surface of the alloy. The attachment is by physical adsorption as the values of heat of adsorption were less than -10 kJ/mol. The plots obtained were linear meaning that they obey the Langmuir and Temkin adsorption isotherms. The inhibition efficiency increases generally with increase in temperature and inhibitor concentration

Corrosion Inhibition Study of Al-Cu-Ni Alloy in Simulated Sea-Water Environment

A study on the inhibition of Al-Cu-Ni alloy in simulated sea-water environment was investigated using Sodium Chromate as inhibitor. The inhibitor concentration was varied as control, 0.25, 0.5, 1.0, 1.5 and 2.0 Molar. Al-Cu-Ni alloy was sand cast into cylindrical bars of 20 mm x 300 mm dimension. The corrosion of the sand-cast and treated alloys in 3.5wt% sodium chloride solution at temperatures 30oC, 50oC and 70oC over 1-5 hrs was evaluated using the weight loss method. It was observed that the corrosion rate of the treated alloys decreases with increase in inhibitor concentration. The decrease in corrosion rate on addition of the inhibitor can be attributed to the adsorption of the inhibitor onto the surface of the alloy. The attachment is by physical adsorption as the values of heat of adsorption were less than -10 kJ/mol. The plots obtained were linear meaning that they obey the Langmuir and Temkin adsorption isotherms. The inhibition efficiency increases generally with increase in temperature and inhibitor concentration